Anlon Healthcare Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 30, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 116 as of 27 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Saroja Pharma Industries India Ltd changed from 16.1 on March 2024 to 14.7 on March 2025 . This represents a CAGR of -4.45% over 2 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 14.11 crore on March 2024 to ₹ 15.18 crore on March 2025 . This represents a CAGR of 3.72% over 2 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 35.78 crore as compare to the Sep '25 revenue of ₹ 52.23 crore. This represent the decline of -31.5% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 12.54 crore as compare to the Sep '25 ebitda of ₹ 13.77 crore. This represent the decline of -8.93% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Anlon Healthcare Ltd changed from ₹ 4.54 crore to ₹ 5.15 crore over 7 quarters. This represents a CAGR of 7.47% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of Anlon Healthcare Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Saroja Pharma Industries India Ltd?

Market cap of Anlon Healthcare Ltd is 616 Cr while Market cap of Saroja Pharma Industries India Ltd is 11 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Saroja Pharma Industries India Ltd?

The stock performance of Anlon Healthcare Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Saroja Pharma Industries India Ltd?

As of March 30, 2026, the Anlon Healthcare Ltd stock price is INR ₹116.0. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹29.35.

How do dividend payouts of Anlon Healthcare Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.